Peptide guide
What is MOTS-c?
Mitochondrial-derived peptide
By PacificRx editorial team · Updated · Educational, not medical advice
The short answer
MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA that, in animal studies, affects metabolism and exercise capacity. There are no published controlled trials in people. It is not FDA-approved; an FDA advisory committee recommended it for compounding in July 2026, pending FDA action.
What is MOTS-c?
MOTS-c is one of a group of small peptides encoded by mitochondria, the cell's energy producers.
What the research shows
Evidence comes from animal and cell studies on insulin sensitivity and metabolism. Whether it does the same in people is unknown.
Side effects and safety
With injected peptides, the most commonly reported problems are injection-site redness, itching or bruising. Because human studies are small, the full side-effect profile is not known; report anything unexpected to your clinician.
FDA and legal status
It is not an FDA-approved drug. When prescribed, it is a compounded preparation made by a licensed pharmacy for an individual patient.
In July 2026 an FDA advisory committee (the Pharmacy Compounding Advisory Committee) voted to recommend adding it to the list of substances 503A pharmacies may compound from. A recommendation is not a listing: FDA has to act before that changes, and FDA staff had advised against it. Ask your clinician how its current status affects prescribing.
Questions
Has MOTS-c been tested in humans?
Not in published controlled trials. Current evidence is from animal and lab research.
Can I get MOTS-c online?
Only with a prescription. At PacificRx you complete an online intake, a clinician licensed in your state decides whether MOTS-c is appropriate, and a licensed U.S. pharmacy prepares it for you. Medication starts at $169/month. Your card is charged only if you are approved. Avoid products sold as "research use only".